Pricing Log in Create free account

Abpro Holdings Inc. (ABPO) vs Virax Biolabs Group Limited (VRAX)

Abpro Holdings Inc. and Virax Biolabs Group Limited are both Biotechnology companies. Virax Biolabs Group Limited is the larger, with a market value of $1.6M against $1.4M — 1.1× the size. Virax Biolabs Group Limited has negative trailing earnings, so its P/E is not meaningful; Abpro Holdings Inc. trades at 0.5×. Across the 9 metrics below, Abpro Holdings Inc. leads on 6 and Virax Biolabs Group Limited on 3.

Valuation

Metric ABPO VRAX Biotechnology median
P/E 0.55 n/m 10.60
P/S n/m — 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.16 0.86 0.66
EV/Sales n/m n/m 9.02
Earnings yield 183.50% (642.17%) (32.88%)
Free cash flow yield (193.29%) 0.00% (23.13%)

Profitability

Metric ABPO VRAX Biotechnology median
Gross margin — — 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (20.18%) 0.00% (51.96%)
Return on assets 46.10% 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABPO VRAX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 94.15% 68.79% 29.88%
Revenue growth, 5-year CAGR — (36.88%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABPO VRAX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.62 9.97 4.97
Net debt to EBITDA 0.01 1.08 1.01

Dividend

Metric ABPO VRAX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ABPO VRAX Biotechnology median
Market cap 1.42m 1.58m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack